# Anagin, Inc.: Form D filings

Anagin, Inc., a pharmaceuticals company in Indianapolis, IN, filed 3 Form D notices with the SEC between 2016 and 2018. The latest, on June 29, 2018, reports $1.3 million sold of a $1.4 million offering to 20 investors.

Find out what Anagin, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Anagin%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Anagin%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fanagin-inc-1679399)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Anagin%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Anagin%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fanagin-inc-1679399)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Indiana](https://specstream.ai/data/form-d/state/indiana): 436 rows, by operating companies, filed since November 1, 2024, $21.80, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/indiana
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: INDIANA CTR FOR BIOMEDIC. INNOV. NOYES P, 5TH FLOOR, STE E504, 1800 N CAPITOL AVE., Indianapolis, IN, 46202
- Phone: (317) 652-1840
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2013
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1679399

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 29, 2018 | New notice | $1,400,000 | $1,308,688 | $91,312 | 20 | Jun 15, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1679399/000167939918000001/0001679399-18-000001-index.htm) |
| Apr 25, 2017 | Amendment | $3,500,000 | $3,050,000 | $450,000 | 23 | Jun 30, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1679399/000167939917000002/0001679399-17-000002-index.htm) |
| Jul 12, 2016 | New notice | $3,000,000 | $950,000 | $2,050,000 | 10 | Jun 30, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1679399/000167939916000001/0001679399-16-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Anantha Shekhar | Director |  |
| Derek Small | Director |  |
| Frank French | Director |  |
| Yvonne Lai | Executive Officer |  |
| Jaswant Gidda | Executive Officer, Director |  |
| James Schulz | Executive Officer |  |
| Nora Doherty | Director |  |

[Every Form D from the week of Jun 25, 2018](https://specstream.ai/data/form-d/week/2018-06-25) · [All recent filings in Indiana](https://specstream.ai/data/form-d/state/indiana) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Anagin, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).